Decreased copy numbers or null genotype of GSTM1 have been associated with hepatotoxicity [31] and higher risk of many cancers including lung cancer [32], gastric cancer [33], and bladder cancer [34]. This evidence concerns the gene GSTM1 and urinary bladder carcinoma.